What I Wish I d Done Before I Lost My Daughter and Mother yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Apr 8, 2021
WEDNESDAY, April 7, 2021 (HealthDay News) Screening and diagnostic mammography volumes decreased in April 2020 compared with April 2019 prepandemic levels but mainly rebounded by July 2020 compared with July 2019, according to a study published online March 29 in the
Journal of the National Cancer Institute.
Brian L. Sprague, Ph.D., from the University of Vermont Larner College of Medicine in Burlington, and colleagues compared monthly screening and diagnostic mammography volumes before and after the pandemic using data on 461,083 screening mammograms and 112,207 diagnostic mammograms conducted during January 2019 through July 2020 at 62 radiology facilities.
The researchers found that in April 2020, screening and diagnostic mammography volumes were 1.1 and 21.4 percent of April 2019 prepandemic volumes, respectively. By July 2020, the volumes had rebounded to 89.7 and 101.6 percent of July 2019 prepandemic volumes, respectively. Through July 2020, the year-to-date
Related Company:
Larner College of Medicine faculty Gary and Janet Stein are principal investigators on a new $9 million grant from the National Cancer Institute to explore the epigenetics of breast cancer with the goal of finding new drug targets. (Photos: Sally McCay, Larner College of Medicine)
Project to Identify New Targets for Drug Treatment That Could Prevent or Halt Disease
Vermont Business Magazine A team of University of Vermont scientists and physician investigators at the UVM Cancer Center and the Northern New England Clinical and Translational Research Network has been awarded a $9 million, five-year grant from the National Cancer Institute (NCI) to investigate the underlying causes of breast cancer with the goal of identifying new cellular-level targets that could be treated with drugs to prevent the disease or halt its progression.
Erica Lamberg
Special to USA TODAY
Airports are notorious for being germ incubators and during a pandemic, this risk rises. As people become vaccinated, widespread travel will become feasible again. But medical experts say there are ways to mitigate the risks while traveling while waiting for the country to reach herd immunity through widespread vaccination.
Although the availability of direct flights is improving, many travelers – especially those who live outside of major cities – have needed to book connecting flights to reach their final destinations during the COVID-19 pandemic.
“Flight layovers are a particularly vulnerable time but it is also a time when you can enact a lot personal safety measures to reduce your risk of contracting disease,” says Dr. Alaina Brinley Rajagopal, a Southern California-based emergency medicine physician, virologist and host of the Emergency Docs podcast.
The team of researchers led by Brian Sprague, PhD, of University of Vermont Larner College of Medicine found that in April 2020, screening rates fell to 1.1% of expected volume based on comparative historical data. By July 2020, that rate rebounded to 89.7%.
However, the group said a substantial cumulative deficit in mammography screening remains, due to missed exam appointments from March through May 2020. In an effort to reduce that deficit, screening rates will need to be above prepandemic levels.
Less information is available on diagnostic mammography, with two studies reporting that volume was reduced by as much as 80% during the early stage of the pandemic, according to the authors